Connor, Clark & Lunn Investment Management Ltd.

Holdings History for ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Symbol: ORMP on Nasdaq
Investment type: Equity / Common Stock par value $0.012 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$124,645	43,735	+15,492	+55%	$2.85	Q4 2025
30 Sep 2025	0%	-0%	$74,562	28,243	-32,206	-53%	$2.64	Q3 2025
30 Jun 2025	0%	-0%	$136,010	60,449	-26,687	-31%	$2.25	Q2 2025
31 Mar 2025	0%	-0%	$186,471	87,136	-19,926		$2.14	Q1 2025
31 Dec 2024	0%	-0%	$259,090	107,062	-4,457	-4%	$2.42	Q4 2024
30 Sep 2024	0%	+0%	$272,106	111,519	+111,519	NEW	$2.44	Q3 2024
31 Mar 2022		-0%	$0	0	-50,786	-100%	$3.17	Q1 2022
31 Dec 2021	0%	+0%	$725,000	50,786	+24,932	+96%	$14.28	Q4 2021
30 Sep 2021	0%	+0%	$568,000	25,854	+25,854	NEW	$21.97	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.